Editor(s):
(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Japan.
(2) Dr. Rafik Karaman, Professor, Al-Quds University, Palestine.
Reviewers:
(1) Manu Mitra, University of Bridgeport, USA.
(2) Samir Mohamed Elrayes, Suez Canal University, Egypt.
(3) Reddi Mohan Naidu Kalla, Sri Venkateswara Engineering College, India.
(4) Chiuyen Phan, The University of Danang, Vietnam.
(5) Ajibo Doris N, University of Port Harcourt, Nigeria.
Additional Reviewers:
(1) Abel Vieira, Nova School of Science and Technology, Portugal.
(2) Ammar A. Razzak Mahmood, University of Baghdad, Iraq.
(3) Hanis Mohd Yusoff, Universiti Malaysia Terengganu, Malaysia.
(4) Long Niu, Dalian Medical University, China.
(5) Mingwan Zhang, University of Connecticut, USA.
(6) Nehal Aly Hamdy, National Research Centre, Egypt.
(7) S.S.Padmapriya, Government College for Women (Autonomous), India.
(8) Shravani Vishwas Girigosavi, Gourishankar Institute of Pharmaceutical Education and Research, India.
(9) Tejinder Kaur, Chandigarh University, India.
(10) Waya Phutdhawong, Silpakorn University, Thailand.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.1/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Manu Mitra, USA) | File 1 | NA
Stage 2 | Peer review report_2 (Samir Mohamed Elrayes, Egypt) | File 1 | NA
Stage 2 | Peer review report_3 (Reddi Mohan Naidu Kalla, India) | File 1 | NA
Stage 2 | Peer review report_4 (Chiuyen Phan, Vietnam) | File 1 | NA
Stage 2 | Peer review report_5 (Ajibo Doris N, Nigeria) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Comment_Editor_2_v1 | File 1 | NA